Alle Storys
Folgen
Keine Story von Eli Lilly and Company mehr verpassen.

Eli Lilly and Company

European School of Oncology Announces Viktoria Kun and Ioanna Soufleri As Joint Winners of ACE Reporter Award 2005

Orlando, Florida (ots/PRNewswire)

Viktoria Kun, Health
Correspondent on the Hungarian national daily newspaper Népszabadság,
and Ioanna Soufleri, Science Editor on the Greek national daily
newspaper To Vima, have been named today by The European School of
Oncology (ESO) as joint winners of the ACE (Awarding Cancer
Enlightenment) Reporter Award 2005. The announcement was made at the
annual meeting of the American Society of Clinical Oncology (ASCO).
This global initiative, launched in 2002, aims to encourage
accurate and informative cancer journalism, and is focussed on
consumer publications, which are key to enlightening the general
public on cancer-related issues.
"The decision to nominate joint winners reflects the impressively
high overall quality of the entries submitted," commented Dr. Alberto
Costa, ESO's Director. "Both Viktoria Kun and Ioanna Soufleri have
been responsible for a series of insightful articles in their
respective newspapers, providing their readers with accurate and
useful information on a range of cancer types."
Kun and Soufleri have been invited to attend the European Cancer
Congress (ECCO) in Paris where they will each be presented with a
cheque for 5,000 Euro at a special award ceremony that will be held
as part of the FECS Presidential Symposium on Wednesday 2nd November
2005. The ACE Reporter Award and travel grant are funded by ESO's
private donors. ECCO will also be the venue for the launch of the
2006 ACE Reporter Award.
A further four entrants were highly commended: Young Joo Song of
the Korea Times has been awarded with a travel grant to attend ECCO
13 in Paris and will also be invited to the Award presentation
ceremony; Clifton Leaf of Fortune Magazine (USA) who will be given a
special mention of appreciation at the annual charity dinner of the
American Italian Cancer Foundation in New York on 15 November 2005;
Mónica Flores Lobato of QUO Mexico who will be congratulated at the
opening ceremony of the ESO Annual course for Latin America in Lima
on 24 November; and Cathy O'Leary of the West Australian who was
presented the award in Sydney a few days ago.
The Award was open to journalists from around the world writing
for newspapers, consumer magazines, newsletters or websites. Entries
were judged on a series of criteria, which included dissemination of
clear, accurate and useful information on cancer to the public;
helping to improve the way cancer patients are treated; and making
the science behind the stories understandable. ESO received 76
entries from 19 different countries.
ESO thanks Eli Lilly and Company, a sustaining member of the
school's "Sharing Progress in Cancer Care" programme, for their
exclusive partnership on this important initiative to help promote
the ACE Reporter Award worldwide. "In sharing ESO's goal of
encouraging excellence in cancer journalism," said Edmundo Muniz, MD,
Vice President of Oncology Products at Eli Lilly and Company, "we
would like to thank all the nominees for their tremendous
contribution to the success of the third ACE Reporter Award."
Notes for Editors
About ESO
Established in 1982, the European School of Oncology is the oldest
non-profit organisation that is exclusively dedicated to increasing
health professional's knowledge of cancer care. With a solid
foundation, rooted in the best tradition of European medicine, ESO
strives to ensure that its educational events are clinically
orientated, multi-professional and evidence based as well as
reflecting the human experience of cancer. The scientific
independence of the School is guaranteed by core funding from
individual donors and a number of charitable foundations. Most of
ESO's events are held in English, however, the School also offers
courses and seminars in German, French, Spanish and Italian. In
addition, the School organises educational events in Latin America,
Russia and the C.I.S., and in the Balkans and Middle East. In
addition to its educational activities ESO keeps the European Cancer
Community abreast of advances in cancer care via its scientific
magazine CancerWorld. Further information about the School is
available from www.cancerworld.org
About Lilly
Lilly, a leading innovation-driven corporation is developing a
growing portfolio of first-in-class and best-in-class pharmaceutical
products by applying the latest research from its own worldwide
laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Indiana, USA, Lilly
provides answers -- through medicines and information -- for some of
the world's most urgent medical needs.

Contact:

Paul George of CPR Worldwide, +1-212-583-9290,
p.george@cprworldwideusa.com ; or Dr. Alberto Costa, Director of
European School of Oncology, Viale Beatrice d'Este 37, 20122 Milan,
Italy, Tel: +39-02-85-46-45-32

Weitere Storys: Eli Lilly and Company
Weitere Storys: Eli Lilly and Company
  • 06.10.2004 – 17:12

    Number, Severity of Fractures Predict Future Risk

    Indianapolis (ots/PRNewswire) - - New Analysis Showed Teriparatide Prevented Fracture Risk Associated with Increasing Number, Severity of Osteoporotic Fractures Data presented at the American Society for Bone and Mineral Research (ASBMR) 26th annual meeting in Seattle, Wash., showed that the number and severity of prior fractures are strong predictors of future fractures in postmenopausal women with ...